Element Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-21,606	Closed	-$494K	–	912
2018 Q2	$494K	Buy	21,606 +4,881	+29%	+$112K	0.01%	379
2018 Q1	$476K	Buy	+16,725	New	+$476K	0.01%	325